Related Experiment Video
Updated: Jun 3, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Recombinant proteins in rheumatology - recent advances
1Department of Internal Medicine I, University Hospital Cologne, Joseph Stelzmann Street 9, 50931 Cologne, Germany. achim.rothe@uk-koeln.de
Abstract:
New targeted anti-inflammatory drugs have revolutionized the therapeutic strategies in rheumatology. Recombinant DNA selection technologies have enabled the isolation and humanization of specific antibody fragments of any specificity that can be 'armed' to deliver effective anti-inflammatory 'payloads'. Antibodies and other targeted provide the opportunity to block key soluble mediators of inflammation in their milieu, or alternatively to block intracellular inflammation-triggering pathways by binding to an upstream cell-surface receptor. Designed proteins can be improved with respect to desired pharmacokinetic and pharmacodynamic effects. They facilitate the delivery of the required immunosuppressive effect. However, the individual extent of desired and undesired effects of a particular biologic therapy can be broader than initially predicted and requires careful evaluation during clinical trials. This review highlights advances in the application of recombinant antibody technology for novel biologic therapies in rheumatology.
Related Concept Videos
Recombinant DNA
Recombinant DNA
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease III: Medical Management
